FDA-Ready Biomanufacturing: Asymchem’s carbapenem API site in Jilin (Dunhua 2) cleared its first short-notice U.S. FDA inspection, marking a key regulatory milestone for continuous-flow production. AI Policy Clash: Nvidia CEO Jensen Huang backed an open letter from 150+ tech firms urging the U.S. to keep open-weight AI models available, pushing back on broad restrictions amid rising China-related scrutiny. Semiconductor Momentum: CXMT’s Shanghai debut IPO follows a surge in memory demand tied to AI, with Reuters reporting a tense Huawei-linked cleanroom standoff that highlights shifting power inside China’s chip supply chain. Mining Automation Export Push: CiDi said overseas deployments should grow this year as it expands autonomous mining equipment sales beyond China, including Australia and plans across the Middle East, South America and Europe. Industrial Chemistry Expansion: CNPC started up its Tarim ethylene Phase II project in Xinjiang, positioning it as a self-sufficiency move integrating renewable power and carbon capture across the chain. Auto Globalization: Changan and China Telecom signed a strategic partnership to build an ecosystem across vehicles, networks, cloud and satellites, while Ford and Geely advanced a Spain JV to produce “multi-energy” vehicles for Europe. Trade Friction: China protested Trump’s new tariffs targeting forced-labor concerns, warning against unilateral trade wars. Logistics Under Strain: Red Sea shipping risk remains elevated as attacks and blockades threaten key routes, adding pressure to energy and freight costs.